Rhelion Life Sciences — Rediscover Health

A Canadian pharmaceutical research and development company advancing therapies for psychiatric and neurological conditions — helping people rediscover health.

Stay Informed

Our Mission

About Rhelion

Rhelion Life Sciences is a Canadian pharmaceutical research and development company dedicated to the discovery and development of novel therapies for psychiatric and neurological conditions. We believe that rigorous science, patient-centred design, and disciplined development can change what is possible in mental and brain health.

Psychiatric and neurological conditions are among the most challenging in medicine — notoriously hard to treat and too often poorly served by existing medications and their side effects. Rhelion exists to change that, advancing therapies that give patients and their families a better path forward.

What We Do

Focus Areas

Psychiatric Conditions

Research programs addressing mood, anxiety, and treatment-resistant psychiatric disorders.

Psychiatric conditions are notoriously difficult to treat, and many patients cycle through therapies that never fully work.
Today's medications too often carry a heavy burden of side effects, leading people to stop treatment that was meant to help.
Millions continue to suffer — and we are working to solve this with better-tolerated, more effective therapies.

Neurological Conditions

Therapeutic candidates targeting neurodegenerative and neuro-inflammatory disease.

Neurological and neurodegenerative diseases are among the hardest conditions in medicine, with few options that meaningfully change their course.
Existing treatments frequently bring significant side effects while offering patients only limited relief.
Too many people and families are left without answers — and we are committed to changing that.

Newsroom

Latest News